EGFR and non-small cell lung carcinoma: In conclusion, we have demonstrated that miR‐134 can down‐regulate EGFR expression in NSCLC cell lines and that overexpression of miR‐134 can inhibit EGFR‐related signaling and suppress NSCLC cells proliferation both in vitro and in vivo.